RABOISSON, PIERRE JEAN-MARIE BERNARD,HU, LILI,VENDEVILLE, SANDRINE,NYANGUILE, ORIGENE,TAHRI, ABDELLAH
申请号：
CA2710644
公开号：
CA2710644C
申请日:
2008.12.23
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The present invention relates to inhibitorsof HCV replication of formula (I), the N-oxide forms, thepharmaceutically acceptable addition salts, the quaternaryamines and the stereochemically isomeric forms thereof,formula (I), wherein R1 R3 and R4 have the meaning de-fined in the claims. The present invention also relates toprocesses for preparing said compounds, pharmaceuticalcompositions containing them and their use in HCV thera-py.
